IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study Bagot, M., Porcu, P., William, B., Vermeer, M., Whittaker, S., Wolff, C., Khodadoust, M., Battistella, M., Paiva, C., Sicard, H., Azim, H., Kim, Y. ELSEVIER SCI LTD. 2018: S29

View details for DOI 10.1016/j.ejca.2018.07.282

View details for Web of Science ID 000443008600079